Ingredient sheet 18-002
Magnesium Chloride
Magnesium Chloride (MgCl₂)
Classification
- Platform category
- Structural & Dermal Support Core (Level 2)
- Functional layer
- Structural & Dermal Support Core
- Ingredient classification
- Structural Component · Functional Component
SIRIAM Platform role
Within the SIRIAM Platform, magnesium chloride functions as one of the principal Structural & Dermal Support Core components.
Its role is to contribute to the common formulation architecture by supporting the aqueous phase of the platform and by providing a recurring functional component within formulations designed according to the Release–Integration concept.
Unlike Regional Signature Components, magnesium chloride is not intended to define anatomical identity. Instead, it contributes to the shared pharmaceutical backbone upon which regional differentiation is built.
Depending on future platform optimisation, regional concentrations may differ while preserving its architectural role within the SIRIAM formulation system.
Scientific rationale
Magnesium is an essential physiological cation involved in hundreds of enzymatic reactions and plays a fundamental role in cellular metabolism, membrane stability, neuromuscular physiology and intracellular signalling.
Experimental research suggests that magnesium ions may influence inflammatory signalling, oxidative stress and epidermal barrier function.
Topical magnesium preparations have been investigated for dermal application; however, the overall clinical evidence remains inconsistent. While several small human studies and experimental investigations suggest local biological activity, systematic reviews conclude that convincing evidence for significant transdermal systemic magnesium absorption is currently lacking.
Within the SIRIAM Platform, magnesium chloride is therefore incorporated because of its pharmaceutical compatibility and plausible local biological rationale, rather than as a means of systemic magnesium supplementation.
Pharmaceutical considerations
Physicochemical Characteristics
- Highly water soluble
- Strongly hygroscopic
- Completely dissociates in aqueous solution
- Compatible with most pharmaceutical aqueous phases
Formulation Considerations
Magnesium chloride should preferably be dissolved completely before incorporation into the emulsion.
Attention should be given to:
ionic strength of the aqueous phase;
possible influence on emulsion viscosity;
compatibility with gelling agents;
preservation system stability;
long-term physical stability.
Higher concentrations may modify rheological behaviour and therefore require validation during formulation development.
Packaging
Compatible with standardized airless dispensing systems when emulsion stability remains within specification.
Protection from excessive moisture during raw material storage is recommended because of its hygroscopic nature.
Current role within the platform
Within the present SIRIAM development platform, magnesium chloride represents one of the recurring Structural Core ingredients.
Its primary architectural role is to support formulation consistency across multiple preparations rather than defining individual regional formulations.
The exact concentration may vary according to future pharmaceutical optimisation and regional formulation requirements.
Development notes
Development Notes
Current platform development indicates satisfactory pharmaceutical compatibility with the standardized vehicle.
Future development may include:
optimisation of concentration;
evaluation of interaction with MSM and Silicea Gel;
optimisation of viscosity for 15 ml airless dispensers;
confirmation of long-term stability during pharmaceutical validation.
Magnesium chloride should remain part of the common platform architecture unless future development demonstrates a clear pharmaceutical reason for regional modification.
Evidence classification
- Level
- B–C
- Assessment
- Strong physiological rationale and experimental evidence. Human evidence for topical local effects is emerging but remains limited, while convincing evidence for clinically relevant systemic absorption through intact skin is currently insufficient.
Relationships
Primary Structural Core relationship
Functional association
Cross references
- Chapter 12 — Structural Matrix
- Chapter 13 — Functional Matrix
- Chapter 15 — Ingredient Design Strategy
- Chapter 17 — Regional Signature Design